Content focuses on the financial impact of data management systems on drug development, manufacturing, and distribution; the basic computer system life cycle model and the activities and software quality assurance practices in each phase; and the controls and methods necessary to maintain data integrity and security.
Guidance Documents
Advanced Manufacturing (1)
+Artificial Intelligence (1)
+Commissioning & Qualification (1)
+Data Integrity (16)
+GAMP® (14)
+Knowledge Management (1)
+Pharma 4.0™ (1)
+Process Analytical Technology (1)
+Quality Assurance (1)
+Quality by Design (1)
+Regulatory (1)
+Validation (12)
+Community Discussions
Community Discussions
Jul 08, 2025
Information Systems
Artificial Intelligence
Data Integrity
Jul 08, 2025
Pharma 4.0™
Jun 20, 2025
Sustainable Facilities, HVAC, & Controlled Environments
Jun 19, 2025
Quality
Lifecycle Management
Validation
May 22, 2025
Apr 24, 2025
Validation
Pharmaceutical Engineering Magazine Articles
White Papers
January / February 2025
GAMP® is indispensable for safeguarding the safety, quality, and compliance of pharmaceutical…
January / February 2024
Stakeholders across industries are becoming accustomed to using information technology (IT) systems…
March / April 2022
This article aims to refresh information on open-source software (OSS) within regulated computerized…

Webinars
Upcoming
On-Demand
ISPE in the News
Latest
-
ISPE Academy's GMP Refresher Certificate Program
-
ISPE Webinar: ISPE Clinical Supply Business Continuity Survey Results and Discussion
-
Varda Raises $187M to Manufacture APIs in Space
-
US FDA Drafts Aluminum Exposure Guidance for Parenteral Drugs
-
Trump Threatens 200% Tariffs on Imported Pharma Products
-
EU to Compile List of Critical Medicines for Stockpile
-
Phlow Temporarily Halts Production After Roof Catches Fire
-
Considerations for Designing Live Biotherapeutic Product Facilities
-
Continuous Manufacturing for mAbs May Leave Smaller Environmental Footprint
- US FDA Layoffs Raise Concerns about Foreign Drug Plant Inspections